Literature DB >> 28914127

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry.

Olivier Bonnot1, Clarissa S Gama2, Eugen Mengel3, Mercè Pineda4, Marie T Vanier5, Louise Watson6, Marie Watissée7, Barbara Schwierin7, Marc C Patterson8.   

Abstract

Objectives: Niemann-Pick disease type C (NP-C) is a rare inherited neurovisceral disease that should be recognised by psychiatrists as a possible underlying cause of psychiatric abnormalities. This study describes NP-C patients who had psychiatric manifestations at enrolment in the international NPC Registry, a unique multicentre, prospective, observational disease registry.
Methods: Treating physicians' data entries describing psychiatric manifestations in NPC patients were coded and grouped by expert psychiatrists.
Results: Out of 386 NP-C patients included in the registry as of October 2015, psychiatric abnormalities were reported to be present in 34% (94/280) of those with available data. Forty-four patients were confirmed to have identifiable psychiatric manifestations, with text describing these psychiatric manifestations. In these 44 patients, the median (range) age at onset of psychiatric manifestations was 17.9 years (2.5-67.9; n = 15), while the median (range) age at NP-C diagnosis was 23.7 years (0.2-69.8; n = 34). Almost all patients (43/44; 98%) had an occurrence of ≥1 neurological manifestation at enrolment. Conclusions: These data show that substantial delays in diagnosis of NP-C are long among patients with psychiatric symptoms and, moreover, patients presenting with psychiatric features and at least one of cognitive impairment, neurological manifestations, and/or visceral symptoms should be screened for NP-C.

Entities:  

Keywords:  Niemann-Pick disease type C; Psychosis; genetics; registry; schizophrenia

Mesh:

Year:  2017        PMID: 28914127     DOI: 10.1080/15622975.2017.1379610

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  10 in total

1.  2-Hydroxypropyl-β-cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of Both Inner and Outer Hair Cells Above a Critical Dose.

Authors:  Xiaopeng Liu; Dalian Ding; Guang-Di Chen; Li Li; Haiyan Jiang; Richard Salvi
Journal:  Neurotox Res       Date:  2020-06-30       Impact factor: 3.911

2.  N-acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease.

Authors:  Rohini Sidhu; Yawo Mondjinou; Mingxing Qian; Haowei Song; Arun Babu Kumar; Xinying Hong; Fong-Fu Hsu; Dennis J Dietzen; Nicole M Yanjanin; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Michael H Gelb; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  J Lipid Res       Date:  2019-06-14       Impact factor: 5.922

3.  Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.

Authors:  Stefano Tozza; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Marcello Esposito; Lucia Ruggiero; Emanuele Spina; Anna De Rosa; Francesco Saccà; Lucio Santoro; Fiore Manganelli
Journal:  Neurol Sci       Date:  2018-03-13       Impact factor: 3.307

Review 4.  Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.

Authors:  Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 5.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

6.  Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.

Authors:  Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Olaf Bodamer; Raymond Y Wang; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Mol Genet Metab       Date:  2020-01-22       Impact factor: 4.204

Review 7.  Miglustat in Niemann-Pick disease type C patients: a review.

Authors:  Mercè Pineda; Mark Walterfang; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2018-08-15       Impact factor: 4.123

8.  Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.

Authors:  Marc C Patterson; Eugen Mengel; Marie T Vanier; Patrick Moneuse; Daniel Rosenberg; Mercedes Pineda
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123

9.  Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia.

Authors:  Alessio Colombo; Lina Dinkel; Stephan A Müller; Laura Sebastian Monasor; Martina Schifferer; Ludovico Cantuti-Castelvetri; Jasmin König; Lea Vidatic; Tatiana Bremova-Ertl; Andrew P Lieberman; Silva Hecimovic; Mikael Simons; Stefan F Lichtenthaler; Michael Strupp; Susanne A Schneider; Sabina Tahirovic
Journal:  Nat Commun       Date:  2021-02-24       Impact factor: 17.694

10.  Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.

Authors:  Carsten Holzmann; Martin Witt; Arndt Rolfs; Veronica Antipova; Andreas Wree
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.